Abstract
Background
Necrotizing fasciitis is a life-threatening soft tissue infection characterized by a rapid spreading infection of the subcutaneous tissue and in particular the fascia. The management of infected tissues requires a rapid diagnosis, immediate aggressive surgical management and an extended debridement. In some cases early amputations of the affected tissues and maximum intensive care treatment, in case of sepsis, are required. Due to a rising number of cases we aimed to evaluate our patients in a retrospective review.
Method
All patients diagnosed with necrotizing fasciitis from 2014 to 2016 (21 months) in our level one trauma center were identified. Their charts were reviewed and data were analyzed in terms of demographic and social information, microbiological results, therapeutic course, socio-economic outcome and mortality.
Results
We found 15 patients with necrotizing fasciitis. None of these died in the observation period. The mean number of surgical interventions was seven. Two patients underwent limb amputation; diabetes mellitus was assigned with a significant higher risk for amputation. The mean hospitalization was 32 days, including 8 days on intensive care unit. Of the discovered bacteria 93% were sensitive to the initial antibiotic treatment with Ampicillin, Clindamycin and Clont.
Conclusion
Surgical therapy is indicated if necrotizing fasciitis is suspected. Diabetes mellitus was a clinical predictor of limb amputation in patients with necrotizing fasciitis in our cohort. Aminopenicillin ± sulbactam in combination with clindamycin and/or metronidazole is recommended as initial calculated antibiotic treatment.
Similar content being viewed by others
References
Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014;51(8):344–62.
Pfanner W. Zur Kenntnis und Behandlung des nekrotisierenden Erysipels. Deutsche Zeitschrift für Chirurgie. 1918;144(1–2):108.
Wilson B. Necrotizing fasciitis. Am Surg. 1952;18(4):416–31.
Frank J, Barker JH, Marzi I. Necrotizing fasciitis of the extremities. Eur J Trauma Emerg Surg. 2008;34(3):229.
Herr M, Grabein B, Palm HG. Nekrotisierende Fasziitis. Der Unfallchirurg. 2011;114(3):197–216.
Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014;1:36.
Lamagni TL, Darenberg J, Luca-Harari B, et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol. 2008;46(7):2359–67.
Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996;335(8):547–54.
Ryssel H, Germann G, Kloeters O, et al. Necrotizing fasciitis of the extremities: 34 cases at a single centre over the past 5 years. Arch Orthop Trauma Surg. 2010;130(12):1515–22.
Lacy MD, Horn K. Nosocomial transmission of invasive group a streptococcus from patient to health care worker. Clin Infect Dis. 2009;49:354–7.
Johansson L, Thulin P, Low DE, et al. Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections. Clin Infect Dis. 2010;51(1):58–65.
Zhu L, Olsen RJ, Nasser W, et al. A molecular trigger for intercontinental epidemics of group A Streptococcus. J Clin Investig. 2015;125(9):3545–59.
O’Seaghdha M, Wessels MR. Streptolysin O and its co-toxin NAD-glycohydrolase protect group A Streptococcus from xenophagic killing. PLoS Pathog. 2013;9(6):e1003394.
Sarani B, Strong M, Pascual J, et al. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg. 2009;208(2):279–88.
Machado N. Necrotizing fasciitis: the importance of early diagnosis, prompt surgical debridement and adjuvant therapy. North Am J Med Sci. 2011;3(3):107.
Chen JL, Fullerton KE, Flynn NM. Necrotizing fasciitis associated with injection drug use. Clin Infect Dis. 2001;33(1):6–15.
Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352:1445–53.
Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535–41.
Goh T, Goh LG, Ang CH, et al. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014;101(1):e119–25.
Wang YS, Wong CH, Tay YK. Staging of necrotizing fasciitis based on the evolving cutaneous features. Int J Dermatol. 2007;46(10):1036–41.
Wall DB, Virgilio C, Black S, et al. Objective criteria may assist in distinguishing necrotizing fasciitis from nonnecrotizing soft tissue infection. Am J Surg. 2000;179:17–21.
Narashiman V, Ooi G, Weidlich S, et al. Laboratory risk indicator for necrotizing fasciitis score for early diagnosis of necrotizing fasciitis in Darwin. ANZ J Surg. 2017. (Epub ahead of print).
El-Menyar A, Asim M, Mudali IN, et al. The laboratory risk indicator for necrotizing fasciitis (LRINEC) scoring: the diagnostic and potential prognostic value. Scand J Trauma Resusc Emerg Med. 2017;25(1):28.
Burner E, Henderson SO, Burke G, et al. Inadequate sensitivity of laboratory risk indicator to rule out necrotizing fasciitis in the emergency department. West J Emerg Med. 2016;17(3):333–6.
Tan JH, Koh BT, Hong CC, et al. A comparison of necrotising fasciitis in diabetics and non- diabetics: a review of 127 patients. Bone Joint J. 2016;98-B(11):1563–1568.
Carbonetti F, Cremona A, Carusi V, et al. The role of contrast enhanced computed tomography in the diagnosis of necrotizing fasciitis and comparison with the laboratory risk indicator for necrotizing fasciitis (LRINEC). Radiol Med. 2015; [Epub ahead of print].
Sun X, Xie T. Management of necrotizing fasciitis and its surgical aspects. Int J Low Extrem Wounds. 2015;14(4):328–34.
Bilton BD, Zibari GB, McMillan RW, et al. Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg. 1998;64(5):397–400.
Wong CH, Yam AK, Tan AB, et al. Approach to debridement in necrotizing fasciitis. Am J Surg. 2008;196(3):e19–24.
Hietbrink F, Bode LG, Riddez L, et al. Triple diagnosis for early detection of ambivalent necrotizing fasciitis. World J Emerg Surg. 2016;11:51.
Misiakos EP, Bagias G, Papadopoulos I, et al. Early diagnosis and surgical treatment for necrotizing fasciitis: a multicenter study. Front Surg. 2017;4:5.
Wall DB, Klein SR, Black S, et al. A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J Am Coll Sure. 2000;191(3):227–31.
Burnham JP, Kirby JP, Kolleg MH. Diagnosis and management of skin and soft tissue infections in the intensive care unit: a review. Intensive Care Med. 2016;42:1899–911.
Chester DL, Waters R. Adverse alteration of wound flora with topical negative-pressure therapy: a case report. Br J Plast Surg. 2002;55:510–1.
Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. S2-Leitlinie HNO: Antibiotikatherapie der Infektionen an Kopf und Hals, 2008.
Khamnuan P, Chongruksut W, Jearwarttanakanok K, et al. Necrotizing fasciitis: epidemiology and clinical predictors for amputation. Int J Gen Med. 2015;8:195–202.
Cheng NC, Tai HC, Chang SC, et al. Necrotizing fasciitis in patients with diabetes mellitus: clinical characteristics and risk factors for mortality. BMC Infect Dis. 2015;15:417.
Elliott DC, Kufera JA, Myers RA. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg. 1996;224(5):672–83.
Frazee BW, Fee C, Lynn J, et al. Community-acquired necrotizing soft tissue infections: a review of 122 cases presenting to a single emergency department over 12 years. J Emer Med. 2008;34(2):139–46.
Dworkin M, Westercamp M, Park L, et al. The epidemiology of necrotising fasciitis including factors associated with death and amputation. Epidemiol Infect. 2009;137:1609–14.
Nisbet M, Ansell G, Lang S, Dzendrowskyj P, Holland D, et al. Necrotising fasciitis: review of 82 cases in South Auckland. Intern Med J. 2011;47:543–8.
Wong CH, Chang HC, Pasupathy S, et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85(8):1454–60.
Singh G, Sinha S, Adhikary S, et al. Necrotising infections of soft tissues—a clinical profile. Eur J Surg. 2002;168:366–71.
Hsiao CT, Weng HH, Yuan YD, et al. Predictors of mortality in patients with necrotizing fasciitis. Am J Emerg Med. 2008;26(2):170–5.
Huang KF, Hung MH, Lin YS, et al. Independent predictors of mortality for necrotising fasciitis: a retrospective analysis in a single institution. J Trauma. 2011;71:467–73.
Park KH, Jung SI, Jung YS, et al. Marine bacteria as a leading cause of necrotizing fasciitis in coastal areas of South Korea. Am J Trop Med Hyg. 2009;80(4):646–50.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
There has been no source of support/funding, either pharmaceutical or industry support. No funding from any organization has been received.
Ethical approval
This retrospective study was approved by the ethic committee of the Johann Wolfgang Goethe-University Frankfurt (352/16).
Conflict of interest
Maximilian Leiblein, Ingo Marzi, Anna Lena Sander, John H. Barker, Federico Ebert and Johannes Frank declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Leiblein, M., Marzi, I., Sander, A.L. et al. Necrotizing fasciitis: treatment concepts and clinical results. Eur J Trauma Emerg Surg 44, 279–290 (2018). https://doi.org/10.1007/s00068-017-0792-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00068-017-0792-8